BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 16825045)

  • 1. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth.
    Patel VV; Zhao L; Wong P; Pradhan BB; Bae HW; Kanim L; Delamarter RB
    Spine J; 2006; 6(4):397-403; discussion 404. PubMed ID: 16825045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth using fibrin glue.
    Patel VV; Zhao L; Wong P; Kanim L; Bae HW; Pradhan BB; Delamarter RB
    Spine (Phila Pa 1976); 2006 May; 31(11):1201-6. PubMed ID: 16688032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
    Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
    Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment.
    Lee TC; Ho JT; Hung KS; Chen WF; Chung YH; Yang YL
    Neurosurgery; 2006 Feb; 58(2):373-80; discussion 373-80. PubMed ID: 16462492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
    Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC
    Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene.
    Cheng SL; Lou J; Wright NM; Lai CF; Avioli LV; Riew KD
    Calcif Tissue Int; 2001 Feb; 68(2):87-94. PubMed ID: 11310352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion.
    Alanay A; Chen C; Lee S; Murray SS; Brochmann EJ; Miyazaki M; Napoli A; Wang JC
    Spine (Phila Pa 1976); 2008 Jul; 33(16):1709-13. PubMed ID: 18580546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel application of high-dose (50kGy) gamma irradiation for demineralized bone matrix: effects on fusion rate in a rat spinal fusion model.
    Alanay A; Wang JC; Shamie AN; Napoli A; Chen C; Tsou P
    Spine J; 2008; 8(5):789-95. PubMed ID: 17996496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.
    Valdes M; Moore DC; Palumbo M; Lucas PR; Robertson A; Appel J; Ehrlich MG; Keeping HS
    Spine J; 2007; 7(3):318-25. PubMed ID: 17482115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
    Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
    Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of plasmid DNA encoding OP-1 protein for spine fusion.
    Bright C; Park YS; Sieber AN; Kostuik JP; Leong KW
    Spine (Phila Pa 1976); 2006 Sep; 31(19):2163-72. PubMed ID: 16946649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
    Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
    Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
    Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
    Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate.
    Takahashi Y; Yamamoto M; Tabata Y
    Biomaterials; 2005 Aug; 26(23):4856-65. PubMed ID: 15763265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation.
    Lee KB; Murray SS; Taghavi CE; Song KJ; Brochmann EJ; Johnson JS; Keorochana G; Liao JC; Wang JC
    Spine J; 2011 Jun; 11(6):568-76. PubMed ID: 21729805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model.
    Namikawa T; Terai H; Hoshino M; Kato M; Toyoda H; Yano K; Nakamura H; Takaoka K
    Spine (Phila Pa 1976); 2007 Oct; 32(21):2294-9. PubMed ID: 17906568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study on repair of the defect of the pars interarticularis in rat with bone morphogenetic protein and fibrin glue].
    Nakamura T
    Nihon Seikeigeka Gakkai Zasshi; 1992 Jul; 66(7):753-62. PubMed ID: 1512486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterolateral lumbar spine fusion with INFUSE bone graft.
    Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of insoluble bone gelatin as a carrier for enhancement of osteogenic protein-1-induced intertransverse process lumbar fusion in a rabbit model.
    Yao G; Qian Y; Chen J; Fan Y; Stoffel K; Yao F; Xu J; Zheng MH
    Spine (Phila Pa 1976); 2008 Aug; 33(18):1935-42. PubMed ID: 18708925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.